{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:57:08Z","timestamp":1791356228018,"version":"4.3.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/ni.3399","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T16:58:10Z","timestamp":1457369890000},"page":"593-603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":83,"title":["Tumor-necrosis factor impairs CD4+ T cell\u2013mediated immunological control in chronic viral infection"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-148X","authenticated-orcid":false,"given":"Marc","family":"Beyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens M","family":"Chemnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Maisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jil","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant V","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Schmidleithner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maren","family":"K\u00f6hne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2195-3666","authenticated-orcid":false,"given":"Robert","family":"Schierwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl S","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Oxenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2236-9074","authenticated-orcid":false,"given":"Thorsten","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-2401","authenticated-orcid":false,"given":"Christian","family":"Kurts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Heikenwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"F\u00e4tkenheuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2983-0414","authenticated-orcid":false,"given":"Percy A","family":"Knolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim L","family":"Schultze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"BFni3399_CR1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nri2802","volume":"10","author":"BT Rouse","year":"2010","unstructured":"Rouse, B.T. & Sehrawat, S. Immunity and immunopathology to viruses: what decides the outcome? Nat. Rev. Immunol. 10, 514\u2013526 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni3399_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O'Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni3399_CR3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter, C.A. & Jones, S.A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448\u2013457 (2015).","journal-title":"Nat. Immunol."},{"key":"BFni3399_CR4","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri2623","volume":"9","author":"G McFadden","year":"2009","unstructured":"McFadden, G., Mohamed, M.R., Rahman, M.M. & Bartee, E. Cytokine determinants of viral tropism. Nat. Rev. Immunol. 9, 645\u2013655 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni3399_CR5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.10.001","volume":"39","author":"SG Deeks","year":"2013","unstructured":"Deeks, S.G., Tracy, R. & Douek, D.C. Systemic effects of inflammation on health during chronic HIV infection. Immunity 39, 633\u2013645 (2013).","journal-title":"Immunity"},{"key":"BFni3399_CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri3806","volume":"15","author":"J Crouse","year":"2015","unstructured":"Crouse, J., Kalinke, U. & Oxenius, A. Regulation of antiviral T cell responses by type I interferons. Nat. Rev. Immunol. 15, 231\u2013242 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni3399_CR7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E.J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"BFni3399_CR8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.coi.2010.02.005","volume":"22","author":"PS Kim","year":"2010","unstructured":"Kim, P.S. & Ahmed, R. Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 22, 223\u2013230 (2010).","journal-title":"Curr. Opin. Immunol."},{"key":"BFni3399_CR9","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","volume":"37","author":"TA Doering","year":"2012","unstructured":"Doering, T.A. et al. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 37, 1130\u20131144 (2012).","journal-title":"Immunity"},{"key":"BFni3399_CR10","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E.J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"BFni3399_CR11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/COH.0b013e32834ddcf2","volume":"7","author":"B Youngblood","year":"2012","unstructured":"Youngblood, B., Wherry, E.J. & Ahmed, R. Acquired transcriptional programming in functional and exhausted virus-specific CD8 T cells. Curr. Opin. HIV AIDS 7, 50\u201357 (2012).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"BFni3399_CR12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro, J.R. et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340, 207\u2013211 (2013).","journal-title":"Science"},{"key":"BFni3399_CR13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","volume":"340","author":"EB Wilson","year":"2013","unstructured":"Wilson, E.B. et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340, 202\u2013207 (2013).","journal-title":"Science"},{"key":"BFni3399_CR14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/COH.0b013e3283454058","volume":"6","author":"F Porichis","year":"2011","unstructured":"Porichis, F. & Kaufmann, D.E. HIV-specific CD4 T cells and immune control of viral replication. Curr. Opin. HIV AIDS 6, 174\u2013180 (2011).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"BFni3399_CR15","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni3399_CR16","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/JVI.02228-07","volume":"82","author":"AR Sedaghat","year":"2008","unstructured":"Sedaghat, A.R. et al. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics. J. Virol. 82, 1870\u20131883 (2008).","journal-title":"J. Virol."},{"key":"BFni3399_CR17","doi-asserted-by":"crossref","first-page":"e1000781","DOI":"10.1371\/journal.ppat.1000781","volume":"6","author":"M Rotger","year":"2010","unstructured":"Rotger, M. et al. Swiss HIV Cohort Study; Center for HIV\/AIDS Vaccine Immunology. Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog. 6, e1000781 (2010).","journal-title":"PLoS Pathog."},{"key":"BFni3399_CR18","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1128\/JVI.01846-10","volume":"85","author":"F Vigneault","year":"2011","unstructured":"Vigneault, F. et al. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J. Virol. 85, 3015\u20133019 (2011).","journal-title":"J. Virol."},{"key":"BFni3399_CR19","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney, E.F., Lee, J.C., Jayne, D.R., Lyons, P.A. & Smith, K.G. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612\u2013616 (2015).","journal-title":"Nature"},{"key":"BFni3399_CR20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus, A., Hayden, M.S. & Ghosh, S. Crosstalk in NF-\u03baB signaling pathways. Nat. Immunol. 12, 695\u2013708 (2011).","journal-title":"Nat. Immunol."},{"key":"BFni3399_CR21","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ng1020","volume":"32","author":"L Prokunina","year":"2002","unstructured":"Prokunina, L. et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat. Genet. 32, 666\u2013669 (2002).","journal-title":"Nat. Genet."},{"key":"BFni3399_CR22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/JVI.65.4.1863-1869.1991","volume":"65","author":"M Salvato","year":"1991","unstructured":"Salvato, M., Borrow, P., Shimomaye, E. & Oldstone, M.B. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J. Virol. 65, 1863\u20131869 (1991).","journal-title":"J. Virol."},{"key":"BFni3399_CR23","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1128\/JVI.00062-07","volume":"81","author":"E Belnoue","year":"2007","unstructured":"Belnoue, E., Fontannaz-Bozzotti, P., Grillet, S., Lambert, P.H. & Siegrist, C.A. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. J. Virol. 81, 7338\u20137350 (2007).","journal-title":"J. Virol."},{"key":"BFni3399_CR24","first-page":"589","volume":"40","author":"LB Doyle","year":"1980","unstructured":"Doyle, L.B., Doyle, M.V. & Oldstone, M.B. Susceptibility of newborn mice with H-2k backgrounds to lymphocytic choriomeningitis virus infection. Immunology 40, 589\u2013596 (1980).","journal-title":"Immunology"},{"key":"BFni3399_CR25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford, A. et al. Molecular and transcriptional basis of CD4+ T cell dysfunction during chronic infection. Immunity 40, 289\u2013302 (2014).","journal-title":"Immunity"},{"key":"BFni3399_CR26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2567.2007.02563.x","volume":"121","author":"CM Graham","year":"2007","unstructured":"Graham, C.M., Christensen, J.R. & Thomas, D.B. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma? Immunology 121, 238\u2013247 (2007).","journal-title":"Immunology"},{"key":"BFni3399_CR27","doi-asserted-by":"crossref","first-page":"28181","DOI":"10.1074\/jbc.M303141200","volume":"278","author":"H Ruan","year":"2003","unstructured":"Ruan, H., Pownall, H.J. & Lodish, H.F. Troglitazone antagonizes tumor necrosis factor-\u03b1-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-\u03baB. J. Biol. Chem. 278, 28181\u201328192 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFni3399_CR28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2006.04.005","volume":"24","author":"Y Sasaki","year":"2006","unstructured":"Sasaki, Y. et al. Canonical NF-\u03baB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24, 729\u2013739 (2006).","journal-title":"Immunity"},{"key":"BFni3399_CR29","doi-asserted-by":"crossref","first-page":"e1001674","DOI":"10.1371\/journal.pbio.1001674","volume":"11","author":"A Sledzin\u0144\u00b4ska","year":"2013","unstructured":"Sledzin\u0144\u00b4ska, A. et al. TGF-\u03b2 signalling is required for CD4+ T cell homeostasis but dispensable for regulatory T cell function. PLoS Biol. 11, e1001674 (2013).","journal-title":"PLoS Biol."},{"key":"BFni3399_CR30","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nri3740","volume":"14","author":"DE Speiser","year":"2014","unstructured":"Speiser, D.E. et al. T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion? Nat. Rev. Immunol. 14, 768\u2013774 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFni3399_CR31","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1126\/science.1175194","volume":"324","author":"JS Yi","year":"2009","unstructured":"Yi, J.S., Du, M. & Zajac, A.J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324, 1572\u20131576 (2009).","journal-title":"Science"},{"key":"BFni3399_CR32","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1172815","volume":"324","author":"A Fr\u00f6hlich","year":"2009","unstructured":"Fr\u00f6hlich, A. et al. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 324, 1576\u20131580 (2009).","journal-title":"Science"},{"key":"BFni3399_CR33","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.1174182","volume":"324","author":"H Elsaesser","year":"2009","unstructured":"Elsaesser, H., Sauer, K. & Brooks, D.G. IL-21 is required to control chronic viral infection. Science 324, 1569\u20131572 (2009).","journal-title":"Science"},{"key":"BFni3399_CR34","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1089\/aid.1997.13.1633","volume":"13","author":"M Nokta","year":"1997","unstructured":"Nokta, M., Rossero, R., Loesch, K. & Pollard, R.B. Kinetics of tumor necrosis factor \u03b1 and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea. AIDS Res. Hum. Retroviruses 13, 1633\u20131638 (1997).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"BFni3399_CR35","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1093\/jac\/dku263","volume":"69","author":"RS De Pablo-Bernal","year":"2014","unstructured":"De Pablo-Bernal, R.S. et al. TNF-\u03b1 levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjects. J. Antimicrob. Chemother. 69, 3041\u20133046 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"BFni3399_CR36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/314572","volume":"179","author":"P Aukrust","year":"1999","unstructured":"Aukrust, P. et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J. Infect. Dis. 179, 74\u201382 (1999).","journal-title":"J. Infect. Dis."},{"key":"BFni3399_CR37","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/infdis\/169.2.420","volume":"169","author":"P Aukrust","year":"1994","unstructured":"Aukrust, P. et al. Serum levels of tumor necrosis factor-\u03b1 (TNF \u03b1) and soluble TNF receptors in human immunodeficiency virus type 1 infection--correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169, 420\u2013424 (1994).","journal-title":"J. Infect. Dis."},{"key":"BFni3399_CR38","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1086\/516510","volume":"176","author":"P Aukrust","year":"1997","unstructured":"Aukrust, P. et al. Effects of intravenous immunoglobulin in vivo on abnormally increased tumor necrosis factor-\u03b1 activity in human immunodeficiency virus type 1 infection. J. Infect. Dis. 176, 913\u2013923 (1997).","journal-title":"J. Infect. Dis."},{"key":"BFni3399_CR39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","volume":"38","author":"M Sade-Feldman","year":"2013","unstructured":"Sade-Feldman, M. et al. Tumor necrosis factor-\u03b1 blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 38, 541\u2013554 (2013).","journal-title":"Immunity"},{"key":"BFni3399_CR40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir, M.E., Butte, M.J., Freeman, G.J. & Sharpe, A.H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26, 677\u2013704 (2008).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni3399_CR41","doi-asserted-by":"crossref","first-page":"20453","DOI":"10.1073\/pnas.1008437107","volume":"107","author":"S Han","year":"2010","unstructured":"Han, S., Asoyan, A., Rabenstein, H., Nakano, N. & Obst, R. Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery. Proc. Natl. Acad. Sci. USA 107, 20453\u201320458 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni3399_CR42","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.1128\/JVI.00825-14","volume":"88","author":"R Plan\u00e8s","year":"2014","unstructured":"Plan\u00e8s, R. et al. HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor \u03b1- and toll-like receptor 4-mediated mechanisms. J. Virol. 88, 6672\u20136689 (2014).","journal-title":"J. Virol."},{"key":"BFni3399_CR43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/ard.2007.081513","volume":"67","author":"EJ Cepeda","year":"2008","unstructured":"Cepeda, E.J., Williams, F.M., Ishimori, M.L., Weisman, M.H. & Reveille, J.D. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann. Rheum. Dis. 67, 710\u2013712 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"BFni3399_CR44","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/rheumatology\/ker190","volume":"50","author":"AMG Brunasso","year":"2011","unstructured":"Brunasso, A.M.G., Puntoni, M., Gulia, A. & Massone, C. Safety of anti-tumour necrosis factor agents in patients with chronic hepatitis C infection: a systematic review. Rheumatology 50, 1700\u20131711 (2011).","journal-title":"Rheumatology"},{"key":"BFni3399_CR45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrrheum.2009.279","volume":"6","author":"SY Kim","year":"2010","unstructured":"Kim, S.Y. & Solomon, D.H. Tumor necrosis factor blockade and the risk of viral infection. Nat. Rev. Rheumatol. 6, 165\u2013174 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFni3399_CR46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.crohns.2009.06.002","volume":"3","author":"SF Habib","year":"2009","unstructured":"Habib, S.F., Hasan, M.Z. & Salam, I. Infliximab therapy for HIV positive Crohn's disease: A case report. J. Crohns Colitis 3, 302\u2013304 (2009).","journal-title":"J. Crohns Colitis"},{"key":"BFni3399_CR47","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1182\/blood-2006-12-064360","volume":"110","author":"JM Chemnitz","year":"2007","unstructured":"Chemnitz, J.M. et al. RNA fingerprints provide direct evidence for the inhibitory role of TGF\u03b2 and PD-1 on CD4+ T cells in Hodgkin lymphoma. Blood 110, 3226\u20133233 (2007).","journal-title":"Blood"},{"key":"BFni3399_CR48","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ni.2084","volume":"12","author":"M Beyer","year":"2011","unstructured":"Beyer, M. et al. Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation. Nat. Immunol. 12, 898\u2013907 (2011).","journal-title":"Nat. Immunol."},{"key":"BFni3399_CR49","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.160.2.521","volume":"160","author":"R Ahmed","year":"1984","unstructured":"Ahmed, R., Salmi, A., Butler, L.D., Chiller, J.M. & Oldstone, M.B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160, 521\u2013540 (1984).","journal-title":"J. Exp. Med."},{"key":"BFni3399_CR50","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/cdd.2012.167","volume":"20","author":"PA Lang","year":"2013","unstructured":"Lang, P.A. et al. Reactive oxygen species delay control of lymphocytic choriomeningitis virus. Cell Death Differ. 20, 649\u2013658 (2013).","journal-title":"Cell Death Differ."}],"updated-by":[{"DOI":"10.1038\/s41590-020-0749-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:00:00Z","timestamp":1593734400000}}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ni.3399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.3399","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ni.3399.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:10:10Z","timestamp":1684447810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni.3399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFni3399"],"URL":"https:\/\/doi.org\/10.1038\/ni.3399","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41590-020-0749-7","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]},"assertion":[{"value":"20 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.B., Z.A., J.M.C., P.H., P.A.K. and J.L.S. have applied for patents for the usage of anti-TNF therapy in chronic viral infection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}